替加色罗
卢比罗斯通
医学
肠易激综合征
耐受性
生活质量(医疗保健)
便秘
临床试验
重症监护医学
替代医学
不利影响
内科学
慢性便秘
病理
护理部
作者
Joy Liu,Darren M. Brenner
摘要
Quality of life and symptom metrics should be standardized and continue to be represented in future IBS-C trials. The choice of agent should be tailored to probability of improving symptoms, safety, tolerability, and cost.
科研通智能强力驱动
Strongly Powered by AbleSci AI